PAR paradigm biopharmaceuticals limited..

Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-68

  1. 1,224 Posts.
    lightbulb Created with Sketch. 235
    Correct me if I am wrong, but the placebo affect won’t impact the bio markers. So I can’t see why they couldn’t release that information once they have analysed it and done their statistical analysis. I am assuming that the analysis will take a while.

    some great commentary on this thread, a huge thanks to all.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
43.0¢
Change
0.010(2.38%)
Mkt cap ! $170.8M
Open High Low Value Volume
42.5¢ 43.5¢ 42.0¢ $61.40K 144.2K

Buyers (Bids)

No. Vol. Price($)
3 19842 43.0¢
 

Sellers (Offers)

Price($) Vol. No.
43.5¢ 2445 1
View Market Depth
Last trade - 10.54am 15/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.